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The mechanism by which inflammation influences
the adaptive response to vaccines is not fully under-
stood. Here, we examine the role of lymph node
macrophages (LNMs) in the induction of the cytokine
storm triggered by inactivated influenza virus vac-
cine. Following vaccination, LNMs undergo inflam-
masome-independent necrosis-like death that is
reliant on MyD88 and Toll-like receptor 7 (TLR7)
expression and releases pre-stored interleukin-1a
(IL-1a). Furthermore, activated medullary macro-
phages produce interferon-b (IFN-b) that induces
the autocrine secretion of IL-1a. We also found that
macrophage depletion promotes lymph node-resi-
dent dendritic cell (LNDC) relocation and affects the
capacity of CD11b+ LNDCs to capture virus and
express co-stimulatory molecules. Inhibition of the
IL-1a-induced inflammatory cascade reduced B cell
responses, while co-administration of recombinant
IL-1a increased the humoral response. Stimulation
of the IL-1a inflammatory pathway might therefore
represent a strategy to enhance antigen presentation
by LNDCs and improve the humoral response
against influenza vaccines.INTRODUCTION
Lymph node macrophages (LNMs) are increasingly subject to
investigation with a particular focus on their role in the initiation
of the immune response (Gray and Cyster, 2012). LNMs can beCell R
This is an open access article under the CC BY-Nclassified as subcapsular sinus or medullary macrophages
(SSMs and MMs, respectively) according to their anatomical po-
sition, expression of different surface markers, and function
(Kuka and Iannacone, 2014).
Located in proximity to the lymph node (LN) follicles, SSMs are
important components of the innate defense barrier, acting as
‘‘flypaper’’ that prevents the dissemination of lymph-borne path-
ogens, including viruses (Farrell et al., 2015; Iannacone et al.,
2010; Junt et al., 2007; Moseman et al., 2012; Winkelmann
et al., 2014), bacteria (Kastenm€uller et al., 2012) and parasites
(Chtanova et al., 2008). In addition to their role in containing in-
fectious agents, SSMs are known for their capacity to present
intact antigen to B cells in the proximal follicles (Carrasco and
Batista, 2007; Gaya et al., 2015; Junt et al., 2007; Phan et al.,
2007, 2009) and processed antigen to T cells (Hickman et al.,
2008). However, the factors that affect the ability of SSMs to
recycle intact antigen or process and present it through the ma-
jor histocompatibility complex (MHC) are yet to be elucidated.
Considering the important role of SSMs as antigen-presenting
cells (APCs), it has been suggested that they may compete
with LN-resident dendritic cells (LNDCs) for antigen capture
and presentation to T or B cells (Gonzalez et al., 2010). MMs
are known for their high phagocytic capacity that is greater
than that of SSMs, and their expression of endosomal degrada-
tive enzymes (Kuka and Iannacone, 2014). However, their rele-
vance in the initiation of immune responses is poorly understood
mainly due to the lack of suitable methods for their specific
depletion.
The ability of LNDCs to capture antigen and induce T cell re-
sponses has been documented previously (Gerner et al., 2015;
Gonzalez et al., 2010; Hickman et al., 2008; Mempel et al.,
2004; Sung et al., 2012; Woodruff et al., 2014). However,
the exact location at which antigen presentation occurs and
the role that LNMs play in dendritic cell (DC) activation remaineports 18, 2427–2440, March 7, 2017 ª 2017 The Author(s). 2427
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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controversial. In addition to the well-characterized DC-T cell
interaction in the LN cortex (Mempel et al., 2004), recent studies
have suggested alternative areas in which this may occur.
Woodruff and colleagues (Woodruff et al., 2014) described the
relocation of DCs from the paracortex to the medullary area
following vaccination. In addition, the interfollicular regions
adjacent to the subcapsular sinus appear to be a preferred
area for the priming of CD8+ (Gerner et al., 2015; Hickman
et al., 2008; Sung et al., 2012) and CD4+ (Gerner et al., 2015;
Woodruff et al., 2014) T cells by DCs. Despite the established
role of DCs in acquiring antigen, not much is known about the
molecular mechanisms that lead to their activation and posi-
tioning in lymphoid tissues and the role that LN macrophages
have in these processes. Cytokines secreted by macrophages
in response to antigen, such as type I interferons (IFNs), have
been postulated to participate in the activation of DCs (Moseman
et al., 2012; Sung et al., 2012) through amechanism that involves
the induction of CXCR3 ligands (Asselin-Paturel et al., 2005).
However, a better understanding of the function of type I IFNs
in the LN and their contribution to DC function is required.
In this study, we report that LNMs initiate an inflammatory
response that leads to the activation of CD11b+ LNDCs through
an interleukin-1a (IL-1a)-mediated process, which is essential for
the elicitation of the humoral response against influenza vaccine.
RESULTS
Influenza Vaccination Induces LN Macrophage
Activation and Promotes Cell Death
To examine macrophage responses to UV-inactivated influenza
virus vaccine (UV-PR8) in the popliteal LN,we employed different
imaging techniques, including two-photon (2PM), electron
microscopy (EM), and confocal microscopy. Three-dimensional
(3D) reconstructions from 2PM images of the popliteal LN
cortical area (Figure 1A) showed a significant decrease in the
number of SSMs at 12 and 48 hr post-vaccination (p.v.) (Fig-
ure 1B). Additionally, the percentage of SSMs and MMs was
reduced over time, whereas the percentage of DCs increased
significantly (Figure 1C).
To further investigate the type of SSM death, we used in vivo
staining with propidium iodide (PI) followed by 2PM imaging of
LNs explanted at 4 hr p.v. (Figure 1D). 3D reconstruction analysis
revealed a clear increase of PI+ SSMs in vaccinated groupsFigure 1. LN Macrophages undergo Necrosis-like Death after Influenz
(A) The top panels show representative 3D reconstructions from 2PM images of po
and 48 hr p.v. (middle and right panels, respectively) following in vivo staining w
unvaccinated control. The bottom panels present cross sections from the corres
(B) Quantitative analysis of 2PM data showing SSM disappearance (nR 5 LNs).
(C) Changes in the percentages of SSMs (CD169+, CX3CR1+), MMs (CD169+, CX3
(D) Representative 3D reconstruction from 2PM images of LN from CX3CR1-GFP
and PI.
(E) Quantitative analysis of 2PM from LN follicular areas showing the increase in nu
follicles).
(F and G) Representative electron micrograph of a SSM (F) and MM (G) at 2 hr p
integrity (blue arrow), mitochondria swelling (green arrow), and multiple phagocyti
evident.
(H) Intravital 2PM sequence from LysMCre-GFP reporter mice (green) showing SS
medullary area; Sub. S, subcapsular sinus area; Fo, follicle; MM, medullary mac
In all figures, the presented data are representative of at least three independencompared toPBS-treatedcontrols (Figure1E), highlighting further
the necrotic nature of SSMdisappearance. To better examine the
morphological features of the dying cells, EM was performed at
2hrp.v.,which revealedsignsof necrosis inbothSSMs (Figure1F)
and MMs (Figure 1G), including loss of plasma membrane integ-
rity,mitochondria swelling, and chromatin condensation.Multiple
endosomes containing viral particles were also detected in the
cytoplasm of the observed cells, demonstrating their active
phagocytic nature. To confirm SSM disappearance in vivo, we
performed intravital 2PM on LysMCre-GFP mice. We observed
that SSMs (sessile and large) that internalizedUV-PR8 underwent
cellular death, as evidenced by the loss of fluorescence, which is
associated with the disruption of the plasma membrane. More-
over, dying SSMsdid not formany blebs that are typically present
in apoptotic cells (Figure 1H; Movie S1).
Using multicolor flow cytometric analysis, we assessed LN
macrophage numbers in response to vaccination. A full descrip-
tion of the applied gating strategy is provided in Figure S1A. We
found that the numbers of both SSMs and MMs were reduced
by UV-PR8 administration by 12 hr p.v. (Figure 2A). We also
observed that SSMs and MMs became rapidly activated
following vaccine administration, as measured by the prominent
upregulation of the early activation marker CD69 (Figures 2B and
2C, respectively; Figure S1B). Importantly, we observed that
LNMs disappeared within the first 3 hr p.v. (Figures 2D and 2E)
and remained absent for at least 1 week in the case of SSMs
(Figure 1F) and 3 days in the case of MMs (Figure 1G).
The observed death mechanism was not exclusively associ-
ated with viral antigen, as SSM and MM numbers were also
significantly reduced after vaccination with heat-inactivated
Streptococcus pneumoniae (Figures S1C and S1D).
SSM Disappearance Is Dependent on Viral
Internalization, TLR7 Recognition, and MyD88
Signaling, while MM Death Is Not
Having observed LNM disappearance, it was of interest to iden-
tify the factors involved in this phenomenon. To evaluate the role
of viral entry in the observed death mechanism, we pretreated
mice with two different anti-influenza antibodies: the neutralizing
antibody H36-7 that binds specifically to the globular head of the
viral hemagglutinin (HA) molecule of the PR8 H1N1 strain, thus
preventing its interaction with the sialic acid (SA) of the target
cell and blocking viral entry (Staudt and Gerhard, 1983), anda Vaccination
pliteal LN fromUV-PR8-administered CX3CR1-GFP reporter mice (green) at 12
ith anti-CD169-PE and anti-CD21/35-PB antibodies. The left panels show the
ponding 3D reconstructions in the top panels. SSMs are indicated in yellow.
CR1), and DCs (CD169, CX3CR1+) in the LN at 12 and 24 hr p.v. (nR 4 LNs).
reporter mice at 4 hr p.v. LNs were stained in vivo with anti-CD169-PB antibody
mber of PI+ CD169+macrophages in the subcapsular sinus at 4 hr p.v. (nR 10
.v. In both cases, clear signs of necrosis, including loss of plasma membrane
c vesicles with virus (red arrow, with higher magnification in the right panel), are
M disappearance at 12 hr p.v. with DiI-labeled UV-PR8 (red) (Movie S1). Med,
rophage; DC, dendritic cell.
t experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.
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Figure 2. LN Macrophages Get Rapidly Activated and Are Absent from the LN during the First 3 Days p.v.
(A) Representative scatterplots from flow cytometric analysis of popliteal LNs showing an evident reduction of SSMs defined as CD3()/B220()/Ly6G()/
Ly6C()/CD11c(inter./low)/CD11b(high)/MHCII(+)/F4/80()/CD169(+) in the popliteal LN at 12 hr p.v.
(B) Representative histogram of fluorescence intensity indicating differences in surface expression of the early activation marker CD69 in SSMs and MMs (C) at
2 hr. p.v. (blue) in comparison with the PBS-injected group (red).
(D–G) Flow cytometric analysis showing the rapid disappearance of SSMs (D) and MMs (E) following vaccine administration (105 PFU/footpad) and their
reappearance at day 20 and day 7 p.v., respectively (F and G).
In all figures, the presented data are representative of at least three independent experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.the anti-fusion antibody FI6 that binds to the stemof theHAmole-
cule, preventing the fusion of the virus with the endosome (Corti
et al., 2011). Strikingly, immunization with H36-7 effectively pre-
vented p.v. SSM death, while pretreatment with FI6 did not (Fig-
ure 3A), confirming that the SA-HA interaction and subsequent
viral internalization is required for SSM death to be induced. In
contrast, MM death was not prevented by H36-7 (Figure 3B),
suggesting that virus internalization is not required for MMs
to disappear. Moreover, SSM and MM disappearance was2430 Cell Reports 18, 2427–2440, March 7, 2017dependent on vaccine dosage, with complete depletion being
induced with 105 plaque-forming units (PFUs) per footpad (Fig-
ures 3C and 3D). In an attempt to induce inflammation without
the presence of virus, we administered alum, an adjuvant known
for its proinflammatory properties. We observed that alum alone
led to a significant reduction in the number of MMs (Figure S2G),
while the number of SSMs remained unaffected (Figure S2F).
A previous study suggested that following parasitic infection,
SSMs disappeared due to infiltrated neutrophils (Chtanova
Figure 3. SSM Disappearance Requires Viral Internalization and Is Dependent on MyD88 and TLR7 Recognition, while MM Does Not
(A and B) Flow cytometric analysis of SSMs (A) and MMs (B) from mice passively immunized with the influenza-neutralizing antibody H36-7 and the anti-fusion
antibody FI6 prior to the administration of UV-inactivated vaccine (UV-PR8). Pre-administration of H36-7 rescues SSMs from death following the administration of
UV-PR8, but not MMs (A and B, respectively).
(C and D) Flow cytometric analysis showing a correlation between the number of SSMs (C) and MMs (D) and influenza vaccine dosage.
(E–H) Flow cytometric analysis of SSMs from MyD88 KO (E) and TLR7 KO (F) mice at 12 hr after administration of UV-PR8 showing that MyD88 and TLR7 are
involved in the intracellular signaling events that lead to SSM death in response to UV-PR8, but not MM death (G and H).
In all figures, the presented data are representative of at least three independent experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.et al., 2008). In our work, we also observed recruitment of natural
killer (NK) cells and neutrophils to the subcapsular sinus (data not
shown). However, when these cells were eliminated using
aNK1.1 and aLy-6G antibodies, respectively, we found that
LNM disappearance remained unaffected (Figures S2C and
S2D). A possible role of migratory DCs in the disruption of the
SSM layer has been reported previously (Gaya et al., 2015).
We found that migratory DCs did not contribute to the observed
phenotype, as vaccinated CCR7 knockout (KO) mice, which
are deficient in DC recruitment to the LN (Martı´n-Fontecha
et al., 2003), exhibited the same SSM response as B6 mice
(Figure S2E).
To determine the role of the inflammasome in this process, we
vaccinated mice deficient in IL-1R, IL-1b, the adaptor protein
ASC (apoptosis-associated speck-like protein with a CARD
domain), or ICE (IL-1b-converting enzyme) and assessed their
SSM numbers by flow cytometry at 12 hr p.v. Contrary to a
recent report that described an inflammasome-dependent
SSM burst in response to vaccinia virus (Sagoo et al., 2016),
we observed a consistent decrease in SSMs in all of the tested
KO strains p.v., confirming that, at least in our model, the inflam-
masome was not involved in LNM death (Figure S2A). In support
of these results, we were not able to detect any upregulation of
the transcripts of IL-1b or IL-18 during the first 24 hr p.v. (Fig-
ure S2B). In contrast, p.v. SSM disappearance was prevented
in MyD88 KO mice (Figure 3E) and in Toll-like receptor7 (TLR7) KO (Figure 3F), which confirmed that the death mecha-
nism is dependent on viral recognition mediated by TLR7
signaling. However, MM death was not prevented in MyD88
KO (Figure 3G) or TLR7 KO (Figure 3H) mice, which suggests
that death is triggered by different pathways in these cell
populations.
LNMacrophages Initiate the Inflammatory Cascade that
Follows Vaccine Administration
To evaluate the role that LNMs have on the initiation of the inflam-
matory response, we focused on the expression of different
proinflammatory molecules after vaccination. Among the tested
cytokines, we detected a rapid and significant secretion of IL-1a
and IFN-b in the LN within the first 90 min p.v. (Figure 4A). To
evaluate the duration and magnitude of the inflammatory reac-
tion, we examined the levels of additional inflammatory mole-
cules in the first 24 hr p.v. We observed a significant peak in
the secretion of MIG, IP-10, KC, MCP-1, MIP-1a, and MIP-1b
at 12 hr, followed by an abrupt decrease by 24 hr p.v. (Figure 4B).
To investigate the role of macrophage death in the induction of
the inflammatory response, we measured the levels of secreted
IFN-b and IL-1a in mice in which LN macrophages had been
depleted with clodronate liposomes (CLLs) prior to vaccination.
We observed that p.v. IFN-b secretion, which we found to be
MyD88 independent, was abolished in CLL-pretreated mice
(Figure 4C, left). Similarly, secretion of IL-1a was inhibited inCell Reports 18, 2427–2440, March 7, 2017 2431
Figure 4. LNMs Are Responsible of the Initial Type I IFN Response that Follows Vaccination
(A) Secretion of the proinflammatory cytokines IL-1a and IFN-b in the first 90 min p.v. Cytokine levels were measured in LN exudates by a cytoplex assay.
(B) Levels of acute-phase cytokines MIG, IP-10, KC, MCP-1, MIP-1a, and MIP-1b in the LN in the first 24 hr p.v. A peak of secretion was measured at 12 hr p.v.
Dotted lines refer to the right-hand axis.
(C) Levels of secreted IFN-b and IL-1a in LNs from macrophage-depleted (CLL-pretreated) and MyD88 KO mice at 12 hr p.v. The expression of these cytokines
requires the existence of macrophage prior to vaccination.
(D) RNA expression levels of the cytokines IL-4 and IL-12 during the first 24 hr that follows vaccination.
In all figures, the presented data are representative of at least three independent experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.this group, although the production of this cytokine was depen-
dent on MyD88 (Figure 4C, right). Moreover, mRNA levels of the
cytokines IL-4 and IL-12, which are important for the differentia-
tion of naive T cells into Th2 and Th1, respectively, were found to
be significantly downregulated at 12 hr p.v. (Figure 4D). Taken
together, these findings suggest that, upon vaccine challenge,
macrophages are key to the production of inflammatory cyto-
kines in the draining LNs.
IFN-b Produced byMMs Triggers the IL-1a Inflammatory
Cascade
To investigate whethermacrophages were the source of the type
I IFN response, we performed intracellular staining of IFN-b at
2 hr p.v. Moreover, since DCs had been previously identified
as a source of IFN-b in the LN (Iannacone et al., 2010), it was
of interest to include them in our investigation. Flow cytometric
analysis showed that both macrophages and DC produced
IFN-b, but to a different extent. Although the IFN-b+ cell count
was similar for both LNMs and DCs, at 2 hr p.v. (data not shown),
the former expressed IFN-b at levels 1,000 times higher than
the latter (Figure 5A, left). Interestingly, a more detailed charac-
terization of the macrophage subtype showed that at 2 hr p.v.,
the majority of IFN-b+ macrophages were MMs (Figure 5B).
These results were further confirmed by immunohistochemical2432 Cell Reports 18, 2427–2440, March 7, 2017analysis in which we observed a prominent expression of
IFN-b that was associated with CD169+ MMs located in the
interfollicular and medullary areas at 2 hr p.v. (Figure 5C),
compared to controls (Figure S3A). Additionally, IFN-b expres-
sion appeared to be induced in a positive feedback loop initiated
bymacrophages, as IF-a/b receptor (IFNAR) KOormacrophage-
depleted (CD169DTR) mice presented significantly lower IFN-b
levels than B6 controls at 12 hr p.v. (Figure 5D).
To study the mechanism of action of IL-1a and IFN-b, we
examined the effect of different concentrations of their recombi-
nant forms alone (without vaccination with UV-PR8). At 12 hr
post-administration (footpad injection) of recombinant IL-1a or
recombinant IFN-b, we measured concentrations of inflamma-
tory cytokines in the LN similar to the ones previously detected
following vaccination. Interestingly, IFN-b was sufficient to
induce secretion of IL-1a, albeit at levels inversely proportional
to the administered dose. Strikingly, both IL-1a and IFN-b were
sufficient to induce the expression of the chemoattractant
protein MCP-1 that is involved in the trafficking of monocytes
and DCs (Figure 5E).
To examine the involvement of LNMs in the expression of
IL-1a, immunostaining was performed in LN sections at 2 hr
p.v., and results confirmed that LN macrophages act as pro-
ducers of this cytokine (Figure 5F). Additionally, intracellular
Figure 5. IFN-b Produced by MM Induces the Expression of IL-1a after Vaccination
(A) Representative results showing intracellular quantification of IFN-b (left) and IL-1a (right) in LNMs (gating strategy described in Figure 1) and DCs
(CD3/CD11chigh/CD169) at 0, 2, and 12 hr p.v. Histograms represent fluorescence intensity that indicates the level of expression of each of the cytokines in the
examined cells.
(B) Representative plots showing intracellular quantification of IFN-b in MM (up) and SSM (down) at 2 hr p.v.
(C) Confocal micrographs showing expression of IFN-b (purple) in the medullary and interfollicular areas of the LN associated with MMs (CD169+; green) at 2 hr
p.v.
(D) Levels of IFN-b in LNs from B6, IFNAR KO, and macrophage-depleted (CD169-DTR) mice at 12 hr p.v.
(E) Detected IL-1a, IFN-b, and MCP-1 levels in the popliteal LN after administration of two concentrations of recombinant IFN-b or IL-1a alone (without UV-PR8)
compared to controls (UV-PR8 or PBS treatments). SD is indicated in brackets; ND indicates non-detectable amounts.
(F) Confocal micrographs showing the expression of IL-1a (red) at 2 hr p.v. associated to LNmacrophages (CD169+; yellow) in the cortical andmedullary area of a
popliteal LN. The follicular area was stained with anti-CD21/35-PB antibody (blue).
(G and H) Levels of IL-1a in LN from B6, IFNAR KO, and macrophage-depleted (CD169-DTR) mice at 12 hr p.v (G) and at 1 hr p.v (H).
In all figures, the presented data are representative of at least three independent experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.staining of IL-1a confirmed that both LNMs and DCs are able to
produce this potent cytokine at 2 hr p.v. (Figure 5A, right). Impor-
tantly, IL-1a expression appeared to be dependent on signaling
through the type I IFN receptor at 12 hr p.v., as IFNAR KO mice
showed significantly lower levels than B6 controls (Figure 5G).
However, the expression of IL-1a at 1 hr p.v. was similar in B6
and IFNAR KOmice, which suggests an IFN-independent mech-
anism in the initial release of this cytokine (Figure 5H).
LNMs Induce the Activation andMigration of LNDCs and
Influence Their Capacity to Present Antigen
Having established the necrotic nature of LNM death and their
response after vaccine administration, we hypothesized thatthe release of inflammatory molecules may mediate the activa-
tion of LNDCs. To investigate a possible link between LNMdeath
and LNDC migratory dynamics, we performed 2PM 3D recon-
struction analysis on CD11c-YFP mice at 12 hr p.v., which re-
vealed an attraction of CD11c+ DCs toward the areas where
LNMs were present (Figure 6A). The analysis of these data
demonstrated a clear decrease in the distance between LNDCs
(mainly located in the paracortex in non-vaccinated animals) and
the LNM layer (Figure 6B). To investigate the effect of macro-
phage-mediated antigen capture by DCs on their capacity to
stimulate CD4 T cells, we isolated DCs from CLL-pretreated
and control mice at 12 hr p.v., co-cultured them in vitro with
HA-specific CD4+ T cells, and measured the division indexCell Reports 18, 2427–2440, March 7, 2017 2433
Figure 6. LNMs Induce the Activation, Migration, and Antigen Presentation Capacity of CD11b+ LNDCs
(A) Representative 2PM showing the position of CD11c-YFP+ cells in a control (left) or vaccinated mouse with respect to the LNM layer (red) at 12 hr p.v.
(B) Representative dot plot of the distance between LNDCs and the nearest macrophage (mm) at 12 hr in control (left) and vaccinated (middle) mice. The y axis
represents mean intensity expressed in arbitrary units (a.u.). Right: chart showing the CD11c+ cells in relation to CD169+ LNMs.
(C) Flow cytometric assessment of the division index of transgenic influenza HA-specific CD4+ T cells after being cocultured for 72 hr with DCs isolated frommice
that had received one of the following treatments: CLL or control liposomes followed by vaccination, vaccine alone, PBS, HA peptide, or no stimulus. DCs were
isolated at 12 hr p.v. (left).
(D) Flow cytometry data showing the number cells in four different DC subpopulations (CD103+, CD8+, pDCs, and CD11b+ DCs) present in the LN at 12 hr p.v.
(E) Levels of secreted MCP-1 in LNs from macrophage-depleted (CLL-treated) and MyD88 KO mice at 12 hr p.v.
(F) Flow cytometry data showing expression levels of CCR2 in LNDCs at 12 hr p.v.
(G) Flow cytometry data showing changes in the GMFI of the different DC subpopulations that have captured DiD-labeled UV-PR8.
(H) Differences in virus uptake in CD11b+ DCs from mice that were administered PBS or UV-PR8-DiD and test groups that were pretreated with clodronate
(CLL)- or PBS-containing liposomes (control liposomes).
(I) GMFI analysis showing differences in surface expression of the costimulatory molecule CD80 at 12 hr p.v. in DCs from vaccinated or PBS-injected mice that
had been pretreated with CLL and coadministered with recombinant IL-1a. Mice deficient in IL-1 receptor were also tested (right).
In all figures, the presented data are representative of at least three independent experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.of the latter. We found that DCs from macrophage-depleted
mice had a significantly impaired ability to stimulate CD4+
T cells, compared to control treatments (Figure 6C), confirming
the requirement of the LNM-DC interaction for effective DC
function.
To study the effect of macrophage-induced inflammation on
LNDCs, we evaluated antigen capture and maturation in four
groups of DCs divided according to their expression of specific
surface markers (Merad et al., 2013) (Figure S4A). We confirmed
that the presence of migratory CD103+ DCs and plasmocytoid
dendritic cells (pDCs) was negligible in the draining LN at 12 hr2434 Cell Reports 18, 2427–2440, March 7, 2017p.v. Interestingly, we also observed a significant increase in the
number of CD8+ DCs and CD11b+ DCs at this time point
(Figure 6D).
To understand the signals that directed themovement of these
cells, and considering that the type I IFN response initiated by
LNMs induced the release of MCP-1 (Figures 5E and 6E), we
analyzed the expression of its receptor, CCR2, in the different
DC subtypes. Interestingly, we observed a significant increase
in the number of CD11b+ DCs that expressed CCR2 (data not
shown) and a prominent upregulation of the expression of this re-
ceptor in these cells at 12 hr p.v. (Figures 6F and S4B).
Figure 7. The Inflammation Initiated by LNMs Is Essential for the
Development of an Effective B Cell Response
(A) Number of influenza-specific IgG ASC in LNs from mice pretreated with
anti-IL-1a compared with a control group vaccinated with UV-PR8 alone or
deficient in the IL-1 receptor (IL-1RKO). LNs were collected at 10 days p.v.
(B) Number of influenza-specific IgG ASC in LNs from mice pretreated with
rIL-1a, rIFN-b, or a combination of these cytokines compared with a control
group vaccinated with UV-PR8 alone. LNs were collected at 10 days p.v.
In all figures, the presented data are representative of at least three indepen-
dent experiments (nR 3). *p < 0.1; **p < 0.01; ***p < 0.001. Error bars, SD.We also observed clear differences in the capacity of the
different DC populations to capture virus, the CD11b+ DC subset
being associated with the highest uptake of the vaccine
(Figure 6G). Moreover, we found that the amount of labeled
UV-PR8 captured by CD11b+ DCs in macrophage-ablated
mice decreased compared to the empty liposomes or the un-
treated groups, as shown by geometric mean fluorescence in-
tensity (GMFI) analysis (Figure 6H). This observation reflected
either the reduction in retained quantity and availability of antigen
in the LN (Gonzalez et al., 2010) due to macrophage depletion or
the reduced ability of DCs to capture antigen because of the lack
of macrophage-induced inflammatory signals.
Moreover, at 12 hr p.v., the expression of the costimulatory
molecules CD80 and CD86 was significantly lower in CD11b+
DCs from CLL-pretreated mice than in the untreated group (Fig-
ures 6I and S4C, respectively). Interestingly, co-administration of
IL-1a and vaccine restored CD80 expression in CLL-pretreated
mice to the same level as in mice administered UV-PR8 alone.
We also confirmed that CD80 expression by CD11b+ DCs was
lower in vaccinated IL-1R KOmice than in the equivalent B6 con-
trols (Figure 6I).
The Inflammatory Cascade Associated with IL-1a
Release Is Essential for Humoral Immunity in the
Draining LN
As mentioned previously, LN macrophages play a critical role in
the initiation of the inflammatory response. Therefore, to study
the effect thatmacrophage-dependent inflammation has on anti-
body production, we performed a series of immunizations in
mice treated with anti-IL-1a antibody and in mice deficient in
IL-1R. We observed that at 10 days p.v., the number of influ-
enza-specific ASC in the draining LN was significantly reduced
compared to the control mice in all of the tested groups, which
highlighted that macrophage-dependent IL-1a-mediated inflam-
mation is required for the development of an effective B cell
response in this organ (Figure 7A). Moreover, to determinewhether IL-1a and IFN-b have an adjuvant action, mice were
immunized with the influenza vaccine alone or vaccine supple-
mented with recombinant IL-1a, IFN-b, or both. Strikingly, at
10 days p.v. the number of ASC were significantly increased in
the groups treated with the recombinant IL-1a and IFN-b in com-
parison with mice treated with the vaccine alone (Figure 7B).
DISCUSSION
Since the identification of macrophage death as an immunolog-
ical reaction (Barth et al., 1995), it has become apparent that this
phenomenon involves the interplay of signaling cascades trig-
gered by the presence of antigen. However, it is only recently
that studies have focused on SSM rupture as an event that mo-
bilizes innate and adaptive immunity (Gaya et al., 2015; Staudt
and Gerhard, 1983).
We observed that following UV-PR8 administration, both
SSMs and MMs undergo necrotic death through a process
that is dependent on vaccine dosage. The mechanism we
describe differs from the one presented in previous studies.
Gaya and colleagues (Gaya et al., 2015) reported that SSM
disappearance was dependent on the infiltration of migratory
DCs. However, in our observations, infiltrated DCs did not
contribute to the described phenotype, as CCR7 KO mice that
are deficient in DC recruitment to the LN showed the same
SSM response as mice in the B6 control group. Moreover, we
observed that SSM death occurs within the first 3 hr after vacci-
nation, much earlier than the time required for DCs to migrate to
the LN (Martı´n-Fontecha et al., 2003), and we could not observe
any recruitment of migratory DCs expressing CD103 in the LN
at 12 hr p.v. Furthermore, Gerner and colleagues (Gerner
et al., 2015) questioned the paradigm that T cell induction is
exclusively mediated by DCs migrating from the peripheral
organs, as these cells require extended periods of time to reach
the draining LN. We also discarded the possibility that LNM
death is affected by infiltrated innate immune cells, as depletion
of NK cells or neutrophils did not prevent macrophage disap-
pearance. Interestingly, Sagoo and colleagues (Sagoo et al.,
2016) described a mechanism by which SSMs undergo
inflammasome-mediated pyroptosis after administration of live
vaccinia virus. In our model, although UV-irradiated influenza
virus retained its ability to enter the host cell, we eliminated
the possible involvement of the inflammasome pathway, given
that depletion of molecules associated with this pathway did
not prevent SSM death.
Importantly, pretreatment with an antibody against the SA
binding site of PR8 HA prevented SSM death, while pretreat-
ment with the FI6 antibody that binds to the fusion domain
of HA did not, indicating that influenza viral entry via the
HA-SA interaction is required to trigger this mechanism.
Once inside the cell, the single-stranded viral RNA is recog-
nized by TLR7 and triggers SSM death in a process that is
dependent of the adaptor protein MyD88. Interestingly, Gaya
and colleagues recently described a mechanism in which
MyD88 was also involved in SSM death following infection
(Gaya et al., 2015).
Previous studies have proposed a model in which SSMs cap-
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B cells in the underlying follicle (Carrasco and Batista, 2007; Junt
et al., 2007). We observed that elimination of SSMs as a conse-
quence of antigen administration occurs soon after vaccination,
and SSMs remain absent for at least 1 week thereafter (Fig-
ure 2F). Therefore, it is unlikely that these cells could play a
role as APCs. However, it could be possible that MMs, which
reappear within the first 7 days p.v. (Figure 2G), might be
involved in antigen presentation, a possibility that requires
further investigation.
We propose an alternative scenario in which the contribution
of LNMs to the adaptive response is associated with their role
in the initiation of the inflammatory response that follows vacci-
nation. This process is initiated by the secretion of IFN-b, which
we found to be dependent on the presence of macrophages.
These results are in agreement with previous reports that
demonstrated an important role for macrophage-produced
type I IFN in different immunological processes such as the
T central memory response against virus (Sung et al., 2012) or
the migration of pDCs from the deep cortex to the SCS area
following viral infection (Asselin-Paturel et al., 2005; Iannacone
et al., 2010). However, in this work, we demonstrated that
MMs, but not SSMs, are the cells principally responsible for
IFN-b secretion. This suggests that the interfollicular regions in
the subcapsular sinus and the medullary part of the LN might
be the most relevant areas in which cell activation and antigen
presentation occur.
Type I IFNs are known to be secreted in response to UV-inac-
tivated influenza virus in a process that is dependent on MyD88
(Diebold et al., 2004), an adaptor protein that plays a key role in
the defense of the host against many pathogens (Seo et al.,
2010). The role of type I IFN is to induce an antiviral state through
the production of proinflammatory cytokines and instruct the
adaptive immune response against the virus (Iwasaki and Pillai,
2014). Macrophage activation following recognition of virus by
TLR results in the expression of nuclear factor kB (NF-kB)-medi-
ated proinflammatory cytokines or the production of IRF7-medi-
ated type I IFN (Iwasaki and Pillai, 2014; Malmgaard et al., 2004).
Surprisingly, we found that vaccine-induced IFN-b production
was MyD88-independent. This result was in contrast to the
role of TLR7 in the induction of IFN-b and suggested an alterna-
tive mechanism that may involve other sensing molecules such
as RIG-I, a previously described type I IFN inducer in infected
and immune cells (Kato et al., 2005). However, we found that
TLR7 recognition and MyD88 signaling were important for the
induction of IL-1a and MCP-1 in a process mediated by the
recognition of influenza single-stranded RNA in the endosomal
compartment of LNMs and DCs. We observed that MMs located
in the interfollicular area (IFA) and medullary area of the LN were
the cell type responsible for initial IFN-b secretion. From their po-
sition in the IFA, these cells could generate an IFN gradient that
might contribute to the activation of nearby SSMs. Moreover, the
administration of recombinant IFN-b alone was sufficient to
induce secretion of IL-1a. In addition, IL-1a production was
impaired in mice deficient in IFNAR or in mice in which macro-
phages had been ablated at 12 hr p.v., confirming the role of
IFN-b in the observed peak in IL-1a secretion.
Our model agrees with the ‘‘inflammatory loop’’ model
described by Di Paolo and Shayakhmetov (Di Paolo and2436 Cell Reports 18, 2427–2440, March 7, 2017Shayakhmetov, 2016) in which inflammation is initiated by
stressed or damage cells via IL-1a-dependent activation of che-
mokines that recruit inflammatory cells to the site of infection.
Interestingly, previous reports have stressed the role of pre-
stored IL-1a as an alarmin molecule involved in the initiation of
the inflammatory response in the context of sterile inflammation
(Rider et al., 2011) or other physiological stimuli (Di Paolo and
Shayakhmetov, 2016). To act as an extracellular alarmin, pro-
IL-1a requires the loss of plasma membrane integrity, which is
indicative of necrotic cell death (Galluzzi et al., 2015). In this
work, we confirmed by EM the loss of plasma membrane integ-
rity in the LNM following influenza vaccination (Figures 1F and
1G). In addition, we observed that LNMs express substantial
amounts of IL-1a at steady state (Figure S3B). Interestingly, we
observed that the initial release of IL-1a was independent of
the type I IF signal. Thus, it might be hypothesized that the early
levels of this cytokinemeasured in the LN are associated with the
necrotic death of macrophages, which constitutively express
and store IL-1a, as confirmed by immunohistochemistry and
fluorescence-activated cell sorting (FACS) studies. However,
the observed peak in expression of IL-1a at 12 hr p.v. is most
likely due to de novo synthesis by LNDCs, triggered by the
disappearance of the LNM.
The observations in ourmodel agree with previous studies that
describe the leakage of cytosolic IL-1a to the surrounding milieu
as a result of cell death caused by injury or infection (Chen et al.,
2007; Eigenbrod et al., 2008). Regarding the source of IL-1a in
the LN, although LNMs and DCs appeared to be the major
producers of this cytokine, we could not discard the contribution
of other myeloid or stromal cells. Similarly, we could not rule out
the possibility that alternative mechanisms other those that
involve IL-1amight affect the activation of DCs in vivo. Addition-
ally, the direct effect of IL-1a on LNDCs needs to be further
evaluated.
In this work, we showed that the type I IFN reaction, initiated
by LNMs, promotes B cell responses to influenza vaccine in
the LN, given that transient treatment with an antibody against
IL-1a reduced immunoglobulin G (IgG) production significantly.
Additionally, co-administration of vaccine and recombinant
IL-1a increased the humoral response in the draining LN. Our
results are in agreement with other studies that suggest that
IL-1a and IL-1b serve as mucosal adjuvants when administered
with soluble protein antigens (Staats and Ennis, 1999).
Different studies have recently demonstrated the capacity of
DCs to relocate to the LN interfollicular areas in which antigen
is captured (Iannacone et al., 2010; Woodruff et al., 2014). How-
ever, the specific effect of the IL-1 inflammatory pathway on DC
activation in the LN is not fully understood. We observed that
CD11b+ DCs in the draining LN have a prominent role capturing
influenza virus. Additionally, IL-1a and IFN-b, initially secreted by
LNMs, contribute to the maturation of this DC subset based on
the effect that these molecules have on the expression of the
costimulatory markers CD80 and CD86. Importantly, IL-1a and
IFN-b induced the expression of MCP-1 that attracts CCR2+
CD11b+ DCs to the areas in which antigen and DAMP from
necrotic SSMs remain. Moreover, the presence of LNMs ap-
peared to be necessary for antigen presentation between
LNDCs and CD4+ T cells, as demonstrated by the lower capacity
of DCs isolated from macrophage-depleted mice to present an-
tigen to influenza-specific CD4+ T cells.
In this study, we provide a link between LNM death in
response to vaccination and the promotion of DC function in
the LN through a mechanism that involves TLR7-mediated viral
recognition and the release of IFN-b and the alarmin molecule
IL-1a. These cytokines activate DCs and stimulate them to
secrete IL-1a in a positive feedback loop. Importantly, secretion
of MCP-1, which is also induced by the type I IFN response,
attracts CCR2+ CD11b+ DCs to the areas with remaining antigen
and DAMP from necrotic SSMs, ensuring effective DC activation
and function.
Based on our results, we can consider the stimulation of the
IL-1a inflammatory pathway as a possible strategy for the
enhancement of APC function in LNDCs and the improvement
of the humoral response against influenza vaccine.
EXPERIMENTAL PROCEDURES
Mice
Mice were bred in-house or acquired from Janvier Labs (C57BL/6) or Charles
River Laboratories (BALB/c). The following transgenic strains were used:
CX3CR1-EGFP (Jung et al., 2000), IL-1R/KO (Labow et al., 1997), IL-1b/KO
(Matsuki et al., 2006), ASC/KO (Mariathasan et al., 2004), ICE/KO (Kuida
et al., 1995), MyD88/KO (Hou et al., 2008), IFNAR KO (M€uller et al., 1994),
LysMcre-GFP (Clausen et al., 1999), TLR-7/KO (Lund et al., 2004), and
influenza HA-specific CD4 T cell receptor a/b (TCR-a/b) (Kirberg et al.,
1994). All strains had the C56BL/6 background except for the HA-specific
CD4 TCR that was on BALB/c. Mice were maintained in specific-path-
ogen-free facilities at the Institute for Research in Biomedicine, Bellinzona.
Experiments were performed in accordance with the Swiss Federal Veteri-
nary Office guidelines, and animal protocols were approved by the veteri-
narian local authorities.
Antigen Administration and Injections
Influenza virus strain A/PR/8/34 was grown, purified, inactivated, and labeled
as described previously (Gonzalez et al., 2010). Different concentrations of
inactivated virus were injected into the footpad of anesthetized mice at
different time points prior to LN collection. Virion dosage ranged from 103
to 105 PFUs per footpad in a final volume of 10 mL. For macrophage deple-
tion, mice were injected in the footpad with 10 mL CLL or PBS-containing
(control) liposomes (Clodronateliposomes.org) at days 5 and 3 prior to immu-
nization. For NK cell and neutrophil depletion, 300 mg of the depletion anti-
bodies aNK1.1 (clone PK136) and aLy-6G (clone 1A8) (BioXCell) were admin-
istered intraperitoneally (i.p.) and intravenously (i.v.) at days 3 and 1 before
vaccine administration, respectively. Macrophage, NK cell, and neutrophil
disappearance following depletion treatment was assessed by FACS (data
not shown). For follicular dendritic cell (FDC) and SSM labeling, mice
received 0.5 mg fluorescence-labeled aCD21/35 and aCD169 (BioLegend),
respectively, which was injected into the footpad 3 to 5 hr prior to image
acquisition. For cytokine blocking, the antibody aIL-1a (clone ALF-161,
BioXCell) was administered i.v. at a dose of 200 mg/animal, as well as footpad
at 61 mg/animal, at the time of vaccination. Recombinant cytokines were
injected at indicated amounts into the footpad at the time of vaccination
and 6 hr p.v., except for the ELISPOT experiment, in which only one injection
of 0.1 mg rIL-1a, 0.25 mg of rIFN-b, or a combination of both was adminis-
tered into the footpad 30 min p.v..
Flow Cytometry
Popliteal LNs were collected, disrupted with tweezers, and digested for
10 min at 37C in an enzyme mix composed of DNase I (0.28 mg/mL, Am-
resco), dispase (1 U/mL, Corning), and collagenase P (0.5 mg/ml, Roche) in
calcium- and magnesium-free PBS (PBS) followed by a stop solution
composed of 2 mM EDTA (Sigma-Aldrich) and 2% heat-inactivated filter-sterilized fetal calf serum (Thermo Fisher Scientific) in PBS (Sigma-
Aldrich). Fc receptors were blocked (aCD16/32, BioLegend) followed by
surface staining and analyzed by flow cytometry on an LSRFortessa
(BD Biosciences). Where indicated, intracellular staining was performed
(88/8824/00, eBioscience) following the manufacturer’s instructions. Data
were analyzed using FlowJo software (TriStar), including the calculation of
division index.
Immunohistology and Microscopy
Mice were anesthetized with a mixture of ketamine (100 mg/kg bodyweight,
Parke Davis) and xylazine (10 mg/kg bodyweight, Bayer) and perfused with
a fixative solution made of 10 mL of 0.05 M phosphate buffer containing
0.1 M L-lysine, 4% paraformaldehyde, and 2 mg/mL NaIO4 at pH 7.4 (PLP).
Popliteal LNs were subsequently collected and incubated in 30% sucrose
phosphate-buffered solution overnight. Tissues were snap frozen in O.C.T.
compound (VWR Chemicals Leuven). 10- to 30-mm sections were cut with a
microtome, blocked with proper sera, and stained with the indicated anti-
bodies (see antibody section). Immunofluorescence confocal microscopy
was performed using a Leica TCS SP5 confocal microscope (Leica Microsys-
tems). Micrographs were acquired in sequential scans and merged to obtain a
multicolor image. Images were analyzed using Imaris software (Bitplane AG).
Transmission electron microscopy was performed as described previously
(Roozendaal et al., 2009).
In Vivo PI Staining
To quantify necrotic SSMs following vaccination, C57BL/6J mice were in-
jected with 10 mL of 107 PFU/mL UV-PR8 into the footpad. 1 hr later, SSM
and LN follicles were labeled by footpad administration of 0.25 mg of fluores-
cently labeled aCD169 and 0.5 mg of aCD21/35 antibodies (BioLegend). 3 hr
later, 20 mg of PI (Sigma-Aldrich) was administered by footpad injection and
LN were harvested immediately. 3D reconstructions of a complete follicular
area and overlying SSM layer were made using two-photon intravital micro-
scopy (150-mm tissue depth). Quantification of necrotic SSMs was performed
using Imaris software based on CD169 expression, PI signal, sphericity, and
volume.
Antibodies
In this study, the following antibodies (BioLegend) were used: aB220
(RA3-6B2), aCD4 (GK1.5), aCD21/35 (7E9), aF4/80 (BM8), aCD40 (3/23),
aCD80 (16-10A1), aCD11c (N418), aCD169 (3D6.112), aCD3 (17A2), aNK1.1
(PK136), aCD11b (M1/70), aCD69 (H1.2F3), aI-A/I-E (M5/114.15.2), aLy-6G
(1A8), aCD16/32 (93), aMHCI (SF1-1.1.1), aGr-1 (RB6-8C5), aCD86 (GL-1),
aLy-6C (HK1.4), aIFN-b (PBL Assay Science), rabbit aIFN-b (Abcam),
aIg(H+L)-AP, aIgG-biot, aIgM-biot (Southern Biotech), aCCR2 (R&D Systems),
H36-7, FI6 (HUMABS BioMed), and depletion antibodies aIL6 (MP5-20F3),
aIL-1a (ALF-161), and rat IgG1 isotype (HRPN) (all from BioXCell).
ELISPOT
Mice were immunized with different doses of UV-inactivated PR8 virus
(103 to 105 PFU per footpad) subcutaneously. For enzyme-linked immuno-
spot assay (ELISPOT), on day 10 p.v., popliteal LNs were removed asepti-
cally, disrupted, and passed through a 40-mm cell strainer. 4 3 105 cells
were plated on UV-PR8-coated (107 PFU/mL) filter plates (MultiScreenHTS,
Merck Millipore) and incubated for 16 hr at 37C. For detection, a biotin-
conjugated aIgG or aIgM was used, followed by streptavidin-conjugated
horseradish peroxidase (HRP). A developing solution consisting of 200 mL
3-amino-9-ethylcarbazole (AEC) solution (Sigma) in 9 mL sodium acetate
buffer containing 4 mL 30% H2O2 was subsequently added. Spots were
read on a C.T.L. ELISPOT reader using ImmunoSpot 5.1 software (Cellular
Technology).
In Vitro Evaluation of Hemagglutinin-Specific Transgenic CD4+ T
Cell Responses
LN-resident DCs were isolated by digestion as described previously (Gonzalez
et al., 2010). Samples were enriched for CD11c+ DCs by magnetic separation
with microbeads (Miltenyi Biotech). Purity was evaluated by FACS and was
always higher than 85%. LNs were collected from T cell antigen receptorCell Reports 18, 2427–2440, March 7, 2017 2437
transgenic mice with expression of an ab T cell antigen receptor specific for
influenza HA peptide, and single-cell suspensions were prepared. Following
lysis of red blood cells by ammonium chloride-potassium bicarbonate buffer
(BioWhittaker, Lonza), cells were labeled for 10 min with 5 mM CFSE (Invitro-
gen) and washed thoroughly. HA-specific CD4+ T cells (23 105) were cultured
for 72 hr together with DCs (5 3 104). Proliferation was measured by flow cy-
tometry and presented as division index.
Cytoplex Assay
LEGENDPlex assays (Mouse Proinflammatory Chemokine Panel and Mouse
Inflammation Panel; BioLegend) were performed to monitor cytokine and
chemokine expression. Briefly, popliteal LNs were collected and carefully
disrupted in 100 mL ice-cold phosphate buffer, minimizing cell rupture. The
suspension was centrifuged at 1,500 rpm for 5 min, and the supernatant
was collected. 25 mL supernatant was used for the protocol following the
manufacturer’s instructions. Samples were analyzed by flow cytometry on
an LSRFortessa (BDBiosciences), and datawere analyzed using LEGENDPlex
software (BioLegend).
qPCR
To measure the expression levels of the cytokines IL-1b, IL-12, IL-4, and
IL-18 the following sets of primers were designed: IL-1b forward,
50-TGTTTTCCTCCTTGCCTC-30; IL-1b reverse, 50-GCTGCCTAATGTCCCC
TT-30; IL-12 forward, 50-TGTGGAATGGCGTCTCTG-30; IL-12 reverse,
50-CAGTTCAATGGGCAGGGT-30; IL-4 forward, 50-GAGCTCGTCTGTA
GGGCT-30; IL-4 reverse, 50-CCGAAAGAGTCTCTGCAG-30; IL-18 forward,
50-GGTTCCATGCTTTCTGGACT-30; and IL-18 reverse, 50-GGCCAAGAG
GAAGTGATTTG-30. Popliteal LNs were collected at 0, 2, 6, 12, and 24 hr
p.v. and disrupted in lysing matrix D 1.4-mm ceramic sphere tubes using
FastPrep-24 tissue disruption (MP Biomedicals), and RNA was isolated using
an RNAeasy Mini kit (QIAGEN). 1 mg of cDNA was synthesized using a cDNA
synthesis kit (Applied Biosystems) following the manufacturer’s recommenda-
tions. For the qPCR reaction, a SYBR Master Mix (Applied Biosystems) was
used, and samples were run on a 7900HT Fast Real-Time PCR System
(Applied Biosystems). Cytokine mRNA levels were expressed relative to
GAPDH expression (primers: GAPDH forward, 50-ACATCATCCCTGCATC
CACT-30; GAPDH reverse, 50-AGATCCACGACGGACACATT-30 ). The Pfaffl
method (Pfaffl, 2001) was used to calculate the relative expression of the
transcripts.
Multiphoton Microscopy and Analysis
Deep tissue imaging was performed on a customized two-photon platform
(TrimScope, LaVision BioTec). Two-photon probe excitation and tissue sec-
ond-harmonic generation (SHG) were obtained with a set of two tunable
Ti:sapphire lasers (Chamaleon Ultra I, Chamaleon Ultra II, Coherent) and an
optical parametric oscillator that emits in the range of 1,010 to 1,340 nm (Cha-
maleon Compact OPO, Coherent), with output wavelength in the range of
690–1,080 nm. The objectives used were a Nikon LWD 163/0.80 numerical
aperture (NA)W in Figure 1A and aNikonNPlan Apo l 43/0.20NA in Figure 5H.
3D reconstructions of whole popliteal LNs (Figure 1A) were made using a
mosaic of up to 33 3 adjacent field-of-view image acquisitions with a z-depth
of up to 300 mm. Images were stitched together using Fiji (Schindelin et al.,
2012) together with a custom-developed script written in Beanshell to auto-
mate image processing. To automate the stitching operations, we developed
a script using Beanshell programming language. The hyperstacks were subse-
quently imported in the software Imaris 7.7.2 (Bitplane) to obtain the 3D
rendering of the LN. Cell populations were segmented (analysis in Figures
1B and 1C) by putting a threshold on the color intensity after background
subtraction.
Statistics
All data are expressed as themean ± SD. For statistical analyses and data rep-
resentation, Prism 6.0b (GraphPad Software) was used. Group comparisons
were assessed using nonparametric tests. All statistical test were two-tailed,
and statistical significance was defined as *p < 0.05, **p < 0.01, and
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Supplementary Information: Figure S1. Related to Figure 1: Phenotypic characterization of SSM and MM.
A) Gating strategy for SSM and MM.
Figure S1, Related to Figure 1: A) Gating stategy for SSM and MM. Results from the PBS-treated control group (left) and vaccinated group at 12 hr p.v. (right) are shown. 
B) Confocal micrograph showing the expression of the surface markers CD3, CD69, CD169 and F4/80 in T cells, SSM and MM at 0 and 2 hr p.v. C) Flow cytometric analysis 
showing a correlation between the SSM and MM (D) dissapearance after vaccination with different dosages of heat-inactivated Streptococcus pneumoniae.  
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Figure S2, Related with Figure 2: (A)  Flow cytometric analysis of SSM and MM from mice deficient in 
IL-1R, IL-1β, ASC and ICE at 12 hr p.v. showing that the inflammasome pathway is not involved in SSM 
 and MM disappearance. (B) mRNA levels of the cytokines IL-1β  and IL-18 measured in the popliteal LN at 
different times following vaccination. C) Flow cytometric analysis of SSM disappearance in mice pre-treated 
with NK-depleting antibody (a-NK) neutrophil-depleting antibody (a-Ly6G) (D) or CCR7 KO (E) compared 
with untreated controls. (F)  Flow cytometric analysis showing the effect of administration of alum alone or 
together with a low viral dose (10  PFU)  in SSM and MM at 12 hr post injection (G). Presented data are 
representative of at least three independent experiments with n ≥ 3. *, P< 0.1; **, P< 0.01; ***, P< 0.001.
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 Figure S2. Related to Figure 2: Molecular characterization of SSM and MM necrotic death.
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Figure S3. Related to Figure 5: Representative confocal micrographs showing the constitutive expression of IFN-β (A) and IL-1α (B) in the popliteal LN (white arrows) 
which is associated with LN macrophages. Presented data are representative of at least three independent experiments with n ≥ 3. Fo stands for B cell follicle. 
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Figure S4. Related to Figure 6: Phenotypic characterization of LNDC. 
Movie S1. Related with Figure 1: 2-photon intravital movie of a popliteal LN starting at 12 hr p.v. 
Subcapsular sinus macrophages (larger static green cells) capture inactivated influenza virus (red). 
The white circle shows a SSM undergoing necrosis, leaving behind the internalized virus. Additionally, 
neutrophils (smaller motile green cells) interact closely with necrotic macrophages capturing viral 
particles.
Movie S1. Related to Figure 1: LN macrophages undergo cell death following influenza vaccination.
